Literature DB >> 8898084

Monoamine neurotransmitter transport mediated by the polyspecific cation transporter rOCT1.

A E Busch1, S Quester, J C Ulzheimer, V Gorboulev, A Akhoundova, S Waldegger, F Lang, H Koepsell.   

Abstract

The polyspecific cation transporter rOCT,1 which is localized in the basolateral membrane of rat renal proximal tubules and in sinusoidal membranes of hepatocytes, was analyzed for transport of monoamine neurotransmitters. In voltage-clamp experiments with rOCT1-expressing Xenopus oocytes, superfusion with dopamine, serotonin, noradrenaline, histamine and the permanent cation acetylcholine induced saturable inwardly directed currents with apparent Km values ranging from 20 to 100 microM. Transport of dopamine was also demonstrated by uptake measurements in oocytes and in the mammalian cell line (HEK 293) which was permanently transfected with rOCT1. The high uptake rates measured in rOCT1-expressing oocytes and in transfected HEK 293 cells suggest that rOCT1 is a high capacity transporter which mediates the first step in the excretion of monoamine neurotransmitters.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8898084     DOI: 10.1016/0014-5793(96)01030-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  24 in total

1.  Effects of brain-derived neurotrophic factor on dopaminergic function and motor behavior during aging.

Authors:  H A Boger; P Mannangatti; D J Samuvel; A J Saylor; T S Bender; J F McGinty; A M Fortress; V Zaman; P Huang; L D Middaugh; P K Randall; L D Jayanthi; B Rohrer; K L Helke; A-C Granholm; S Ramamoorthy
Journal:  Genes Brain Behav       Date:  2010-10-19       Impact factor: 3.449

2.  Common drugs inhibit human organic cation transporter 1 (OCT1)-mediated neurotransmitter uptake.

Authors:  Kelli H Boxberger; Bruno Hagenbuch; Jed N Lampe
Journal:  Drug Metab Dispos       Date:  2014-03-31       Impact factor: 3.922

3.  Organic cation transporter inhibition increases medial hypothalamic serotonin under basal conditions and during mild restraint.

Authors:  Na Feng; Christopher A Lowry; Jodi L Lukkes; Miles Orchinik; Gina L Forster; Kenneth J Renner
Journal:  Brain Res       Date:  2010-02-19       Impact factor: 3.252

4.  Distinct characteristics of organic cation transporters, OCT1 and OCT2, in the basolateral membrane of renal tubules.

Authors:  Y Urakami; M Okuda; S Masuda; M Akazawa; H Saito; K Inui
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

5.  Characteristics of choline transport across the blood-brain barrier in mice: correlation with in vitro data.

Authors:  H Murakami; N Sawada; N Koyabu; H Ohtani; Y Sawada
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

6.  Inhibitory potencies of trimipramine and its main metabolites at human monoamine and organic cation transporters.

Authors:  Britta Haenisch; Christoph Hiemke; Heinz Bönisch
Journal:  Psychopharmacology (Berl)       Date:  2011-04-12       Impact factor: 4.530

7.  Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters.

Authors:  J J Chen; Z Li; H Pan; D L Murphy; H Tamir; H Koepsell; M D Gershon
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

8.  Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission.

Authors:  Paul J Gasser; Christopher A Lowry; Miles Orchinik
Journal:  J Neurosci       Date:  2006-08-23       Impact factor: 6.167

9.  Polyamine transport by the polyspecific organic cation transporters OCT1, OCT2, and OCT3.

Authors:  Monica Sala-Rabanal; Dan C Li; Gregory R Dake; Harley T Kurata; Mikhail Inyushin; Serguei N Skatchkov; Colin G Nichols
Journal:  Mol Pharm       Date:  2013-03-19       Impact factor: 4.939

10.  Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice.

Authors:  Nicole L Baganz; Rebecca E Horton; Alfredo S Calderon; W Anthony Owens; Jaclyn L Munn; Lora T Watts; Nina Koldzic-Zivanovic; Nathaniel A Jeske; Wouter Koek; Glenn M Toney; Lynette C Daws
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.